Latest Insider Transactions at Johnson & Johnson (JNJ)
This section provides a real-time view of insider transactions for Johnson & Johnson (JNJ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of JOHNSON & JOHNSON to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of JOHNSON & JOHNSON's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 12
2021
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
14,444
+4.34%
|
-
|
|
Feb 12
2021
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,414
-3.23%
|
$728,310
$165.55 P/Share
|
|
Feb 12
2021
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,362
+6.91%
|
-
|
|
Feb 12
2021
|
Joseph J Wolk Exec VP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,456
-3.02%
|
$240,240
$165.55 P/Share
|
|
Feb 12
2021
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,086
+9.89%
|
-
|
|
Feb 12
2021
|
Robert J Decker VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
486
-1.67%
|
$80,190
$165.55 P/Share
|
|
Feb 12
2021
|
Robert J Decker VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,310
+4.36%
|
-
|
|
Feb 12
2021
|
Alex Gorsky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
31,706
-3.14%
|
$5,231,490
$165.55 P/Share
|
|
Feb 12
2021
|
Alex Gorsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
75,105
+6.8%
|
-
|
|
Feb 12
2021
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Payment of exercise price or tax liability
|
Direct |
3,375
-4.01%
|
$556,875
$165.55 P/Share
|
|
Feb 12
2021
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
7,145
+8.0%
|
-
|
|
Dec 09
2020
|
Michael E Sneed EVP, Global Corp Aff & CCO |
SELL
Open market or private sale
|
Direct |
54,662
-49.36%
|
$8,308,624
$152.93 P/Share
|
|
Dec 09
2020
|
Michael E Sneed EVP, Global Corp Aff & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
54,662
+33.05%
|
$3,389,044
$62.2 P/Share
|
|
Nov 25
2020
|
Alex Gorsky Director |
SELL
Bona fide gift
|
Direct |
20,950
-2.33%
|
-
|
|
Sep 14
2020
|
Alex Gorsky Director |
BUY
Acquisition or disposition by will or laws
|
Direct |
2,750
+0.6%
|
-
|
|
Sep 02
2020
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Open market or private sale
|
Direct |
16,115
-11.46%
|
$2,465,595
$153.52 P/Share
|
|
Sep 02
2020
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,115
+10.28%
|
$1,015,245
$63.79 P/Share
|
|
Jul 28
2020
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Open market or private sale
|
Direct |
29,000
-57.22%
|
$4,263,000
$147.47 P/Share
|
|
Mar 13
2020
|
William D Perez Director |
BUY
Open market or private purchase
|
Direct |
500
+3.02%
|
$63,500
$127.69 P/Share
|
|
Feb 21
2020
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Open market or private sale
|
Direct |
39,224
-52.27%
|
$5,765,928
$147.96 P/Share
|
|
Feb 21
2020
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
19,224
+20.39%
|
$1,730,160
$90.44 P/Share
|
|
Feb 13
2020
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,393
-4.78%
|
$1,558,950
$150.46 P/Share
|
|
Feb 13
2020
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,231
+9.35%
|
-
|
|
Feb 13
2020
|
Robert J Decker VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
555
-2.01%
|
$83,250
$150.46 P/Share
|
|
Feb 13
2020
|
Robert J Decker VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,499
+5.24%
|
-
|
|
Feb 13
2020
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
43,904
-6.98%
|
$6,585,600
$150.46 P/Share
|
|
Feb 13
2020
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
105,668
+14.19%
|
-
|
|
Feb 13
2020
|
Alex Gorsky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
45,471
-4.67%
|
$6,820,650
$150.46 P/Share
|
|
Feb 13
2020
|
Alex Gorsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
107,016
+9.98%
|
-
|
|
Feb 13
2020
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Payment of exercise price or tax liability
|
Direct |
5,832
-5.3%
|
$874,800
$150.46 P/Share
|
|
Feb 13
2020
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
13,747
+11.49%
|
-
|
|
Feb 13
2020
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Payment of exercise price or tax liability
|
Direct |
1,444
-1.27%
|
$216,600
$150.46 P/Share
|
|
Feb 13
2020
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
3,692
+3.17%
|
-
|
|
Feb 13
2020
|
Michael E Sneed EVP, Global Corp Aff & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,140
-4.29%
|
$771,000
$150.46 P/Share
|
|
Feb 13
2020
|
Michael E Sneed EVP, Global Corp Aff & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,836
+9.23%
|
-
|
|
Feb 13
2020
|
Paulus Stoffels Vice Chair, Exec Committee |
SELL
Payment of exercise price or tax liability
|
Direct |
16,101
-3.01%
|
$2,415,150
$150.46 P/Share
|
|
Feb 13
2020
|
Paulus Stoffels Vice Chair, Exec Committee |
BUY
Exercise of conversion of derivative security
|
Direct |
39,381
+6.89%
|
-
|
|
Feb 13
2020
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Payment of exercise price or tax liability
|
Direct |
8,228
-3.62%
|
$1,234,200
$150.46 P/Share
|
|
Feb 13
2020
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
16,084
+6.72%
|
-
|
|
Feb 13
2020
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,413
-3.12%
|
$1,411,950
$150.46 P/Share
|
|
Feb 13
2020
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,326
+6.34%
|
-
|
|
Feb 13
2020
|
Joseph J Wolk Exec VP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,091
-5.01%
|
$313,650
$150.46 P/Share
|
|
Feb 13
2020
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,080
+15.35%
|
-
|
|
Feb 13
2020
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,112
-5.58%
|
$1,066,800
$150.46 P/Share
|
|
Feb 13
2020
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,809
+11.4%
|
-
|
|
Feb 03
2020
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Payment of exercise price or tax liability
|
Direct |
23,721
-19.22%
|
$3,534,429
$149.32 P/Share
|
|
Feb 03
2020
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
48,312
+28.13%
|
-
|
|
Feb 03
2020
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Payment of exercise price or tax liability
|
Direct |
15,405
-26.49%
|
$2,295,345
$149.32 P/Share
|
|
Feb 03
2020
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
38,650
+39.93%
|
-
|
|
Jan 30
2020
|
Michael E Sneed EVP, Global Corp Aff & CCO |
SELL
Open market or private sale
|
Direct |
58,128
-54.07%
|
$8,661,072
$149.39 P/Share
|